Ng S, Kilburn LS, Kirby AM, Griffin C, et al. Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial. Radiother Oncol 2025;211:111056.
PMID: 40712928